Cargando…
Off-Patent Generic Medicines vs. Off-Patent Brand Medicines for Six Reference Drugs: A Retrospective Claims Data Study from Five Local Healthcare Units in the Lombardy Region of Italy
The scientific documentation supporting the potential clinical and economic benefits of a growing use of off-patent generic drugs in clinical practice seems to be limited in Italy as yet. METHODS: We compared differences in outcomes between off-patent generic drugs and off-patent brand drugs in real...
Autores principales: | Colombo, Giorgio L., Agabiti-Rosei, Enrico, Margonato, Alberto, Mencacci, Claudio, Montecucco, Carlo Maurizio, Trevisan, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867455/ https://www.ncbi.nlm.nih.gov/pubmed/24367576 http://dx.doi.org/10.1371/journal.pone.0082990 |
Ejemplares similares
-
Off-patent drugs at brand-name prices: a puzzle for policymakers
por: Tallapragada, Naren P.
Publicado: (2016) -
The Impact of Reimbursement Practices on the Pharmaceutical Market for Off-Patent Medicines in Slovakia
por: Tesar, Tomas, et al.
Publicado: (2021) -
Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis
por: Vandenplas, Yannick, et al.
Publicado: (2021) -
Determinants of prescribing decisions for off-patent biological medicines in Belgium: a qualitative study
por: Vandenplas, Yannick, et al.
Publicado: (2022) -
The extent to which off-patent registered prescription medicines are used for off-label indications in Australia: A scoping review
por: Howe, Katrina, et al.
Publicado: (2021)